The Department of Health, Disability and Ageing has registered Amendment Determination 2026 (No. 3) to the National Health (Commonwealth Price) Determination 2019, effective 31 March 2026. This legislative instrument updates Commonwealth pricing and payment conditions for pharmaceutical benefits supply under the National Health Act 1953. The specific amendments are detailed in Schedule 1 of the instrument, with the instrument number F2026L00406.

Pharmaceutical suppliers and healthcare providers participating in the Commonwealth pharmaceutical benefits system should review the updated Schedule 1 amendments to identify any changes affecting their products or reimbursement arrangements. As a registered legislative instrument, these pricing amendments are binding for parties supplying Commonwealth-funded pharmaceutical benefits. No specific compliance deadline or comment period is stated as this is a final registered determination.